Sartorius Stedim Biotech SA Cash Flow Conversion Efficiency

Latest as of June 2026: 0.030x

Sartorius Stedim Biotech SA cash flow conversion efficiency. Based on the latest financial reports, Sartorius Stedim Biotech SA (DIM) has a cash flow conversion efficiency ratio of 0.030x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€129.50 Million ≈ $151.40 Million USD) by net assets (€4.25 Billion ≈ $4.97 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see DIM market cap overview for the company's overall valuation and market capitalisation.

Cash Flow Conversion Efficiency of Sartorius Stedim Biotech SA (2005–2025)

Cash flow conversion efficiency of Sartorius Stedim Biotech SA from 2005 to 2025. This chart illustrates how Sartorius Stedim Biotech SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View DIM stock price for real-time trading data and today's change.

Sartorius Stedim Biotech SA Cash Flow Conversion Ratio Explained

Sartorius Stedim Biotech SA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Sartorius Stedim Biotech SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sartorius Stedim Biotech SA ranked by their cash flow conversion efficiency. Review Sartorius Stedim Biotech SA (DIM) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Company	Cash Flow Conversion Efficiency
BANCO BRANDESCO SP.ADR 1 F:BREA	-0.111x
Jardine Matheson Holdings Limited F:H4W	0.025x
Broadridge Financial Solutions Inc NYSE:BR	0.107x
INTERCONT HOTELS F:IC1B	N/A
Banco de Chile F:G4RA	-0.033x
SAIC Motor Corp Ltd SHG:600104	0.041x
Amerize Inc. SW:AMRZ	0.033x
Woodward Inc NASDAQ:WWD	0.044x

Annual Cash Flow Conversion Efficiency for Sartorius Stedim Biotech SA (2005–2025)

The table below shows the annual cash flow conversion efficiency of Sartorius Stedim Biotech SA from 2005 to 2025. Also see DIM current and non-current assets for a full breakdown of the balance sheet.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€4.13 Billion ≈ $4.82 Billion	€538.60 Million ≈ $629.68 Million	0.131x	-35.56%
2024-12-31	€4.02 Billion ≈ $4.70 Billion	€815.10 Million ≈ $952.94 Million	0.203x	-27.45%
2023-12-31	€2.67 Billion ≈ $3.13 Billion	€746.40 Million ≈ $872.62 Million	0.279x	+14.65%
2022-12-31	€2.51 Billion ≈ $2.94 Billion	€612.30 Million ≈ $715.84 Million	0.244x	-39.35%
2021-12-31	€1.73 Billion ≈ $2.03 Billion	€695.97 Million ≈ $813.66 Million	0.402x	+42.84%
2020-12-31	€1.48 Billion ≈ $1.73 Billion	€416.88 Million ≈ $487.38 Million	0.281x	+6.75%
2019-12-31	€1.18 Billion ≈ $1.38 Billion	€310.13 Million ≈ $362.57 Million	0.263x	+21.07%
2018-12-31	€1.04 Billion ≈ $1.22 Billion	€227.29 Million ≈ $265.72 Million	0.218x	+9.51%
2017-12-31	€879.45 Million ≈ $1.03 Billion	€174.69 Million ≈ $204.23 Million	0.199x	-3.19%
2016-12-31	€763.56 Million ≈ $892.68 Million	€156.66 Million ≈ $183.15 Million	0.205x	-7.00%
2015-12-31	€647.22 Million ≈ $756.67 Million	€142.79 Million ≈ $166.94 Million	0.221x	+6.73%
2014-12-31	€538.51 Million ≈ $629.58 Million	€111.31 Million ≈ $130.14 Million	0.207x	+10.53%
2013-12-31	€481.84 Million ≈ $563.32 Million	€90.11 Million ≈ $105.34 Million	0.187x	+66.16%
2012-12-31	€434.72 Million ≈ $508.24 Million	€48.93 Million ≈ $57.20 Million	0.113x	-26.52%
2011-12-31	€395.63 Million ≈ $462.53 Million	€60.59 Million ≈ $70.84 Million	0.153x	-23.15%
2010-12-31	€365.07 Million ≈ $426.80 Million	€72.76 Million ≈ $85.06 Million	0.199x	-14.69%
2009-12-31	€393.20 Million ≈ $459.69 Million	€91.86 Million ≈ $107.39 Million	0.234x	+83.84%
2008-12-31	€371.65 Million ≈ $434.49 Million	€47.23 Million ≈ $55.21 Million	0.127x	+77.15%
2007-12-31	€362.76 Million ≈ $424.10 Million	€26.02 Million ≈ $30.42 Million	0.072x	-76.57%
2006-12-31	€168.93 Million ≈ $197.50 Million	€51.72 Million ≈ $60.46 Million	0.306x	+3.56%
2005-12-31	€148.35 Million ≈ $173.44 Million	€43.85 Million ≈ $51.27 Million	0.296x	--

About Sartorius Stedim Biotech SA

PA:DIM France Medical Instruments & Supplies

Market Cap

$25.23 Billion

€21.58 Billion EUR

Market Cap Rank

#1367 Global

#32 in France

Share Price

€221.80

Change (1 day)

+2.31%

52-Week Range

€151.50 - €223.00

All Time High

€542.33